Table 2.

Characteristics of the patients with postoperative VTE.

	VTE days after surgery	PE or DVT	Symptomatic	Advanced ACC	Metastasis before surgery	Use LMWH during development VTE	Type of surgery is laparoscopy	Use OCP	Smoking	Functional tumor	Fatal outcome
Case 1	4	PE	Yes	No	No	No, received 2 days postoperative LMWH	Yes	NA, Male	No	Subclinical hypercortisolism	No
Case 2	10	PE	Yes	Yes	No	No, received 2 days postoperative LMWH	Yes	Yes	Yes	No	No
Case 3	20	PE	No	Yes	Lung metastasis	Yes, prophylactic dose	No	No	No	Cortisol and androgen production	No
Case 4	28	PE	Yes	Yes	Lymph metastasis	Yes, prophylactic dose	No	No	No	Overt hypercortisolism	Yes
Case 5	52	PE	Yes	Yes	No	Yes, therapeutic dose because of tumor thrombus	No	NA, Male	No	Over hypercortisolism	No
Case 6	64	PE	No	Yes	Liver metastasis	No, received 42 days postoperative LMWH	No	No	No	No	No
Case 7	65	PE	No	Yes	Lung metastasis	No, received 5 days postoperative LMWH	No	No	No	Cortisol and androgen production	No
Case 8	146	PE	Yes	Yes	No	Yes, therapeutic dose because of tumor thrombus	No	No	No	Cortisol and androgen production	No

ACC, adrenocortical carcinoma; DVT, deep venous thrombosis; LMWH, low-molecular-weight heparin; NA, not applicable; OCP, oral contraceptive; PE, pulmonary embolism; VTE, venous thromboembolic events.